Sign In
Buy SVRA
$5.25
+0 (+0%)
At Close: Jun 03, 2026
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
11:05am, Thursday, 30'th Oct 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:30am, Thursday, 30'th Oct 2025
LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Savara Inc. (“Savara” or “
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers – SVRA
10:00am, Thursday, 30'th Oct 2025
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) and certain office
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Savara Inc.(SVRA) Shareholders
08:45am, Thursday, 30'th Oct 2025
NEW YORK , Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA). Shareholders who purchased shares of SVRA during the class period
Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants
09:43pm, Wednesday, 29'th Oct 2025
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten public offe
Savara Inc. (SVRA) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
04:48pm, Wednesday, 29'th Oct 2025
LOS ANGELES , Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Savara Inc. ("S
Savara Announces Proposed Public Offering
04:07pm, Wednesday, 29'th Oct 2025
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has commenced an und
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $75 million royalty funding agre
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Savara Inc.
01:00am, Wednesday, 29'th Oct 2025
NEW YORK , Oct. 29, 2025 /PRNewswire/ -- A securities fraud class action lawsuit against Savara Inc. (NASDAQ: SVRA) is pending. The lawsuit was filed by Pomerantz LLP.
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Savara Inc.
09:39pm, Tuesday, 28'th Oct 2025
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- A securities fraud class action lawsuit against Savara Inc. (NASDAQ: SVRA) is pending. The lawsuit was filed by Pomerantz LLP. A previous press release sta
Investors who lost money on Savara Inc. (SVRA) should contact Levi & Korsinsky about pending Class Action - SVRA
03:37pm, Tuesday, 28'th Oct 2025
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit.
Portnoy Law Firm Announces Class Action on Behalf of Savara, Inc. Investors
01:46pm, Tuesday, 28'th Oct 2025
LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Savara, Inc., (“Savara” or the "Company") (NASDAQ: SVRA) investors off a class action on behalf of investors that bought
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
10:00am, Tuesday, 28'th Oct 2025
NEW YORK , Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) and certain officers. The c
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
09:58am, Tuesday, 28'th Oct 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options If you purchased or acquired
